
LINK . SPRINGER . COM {
}
Title:
A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis | Cancer Immunology, Immunotherapy
Description:
Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam − , AroA − ) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Politics
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don't see any clear sign of profit-making.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {🔍}
article, tumor, cancer, pubmed, cas, google, scholar, vaccine, xiang, minigene, reisfeld, legumain, mizutani, zhou, luo, vaccines, research, breast, angiogenesis, macrophages, tams, antigen, access, dna, privacy, cookies, content, van, usa, publish, search, immunotherapy, stroma, growth, rong, mice, cell, tcell, clin, res, data, protection, information, log, journal, immunology, september, lewēn, markowitz, yunping,
Topics {✒️}
t-cell immunotherapy revives oral minigene vaccines darmstadt-lexigen research center t-cell-mediated suppression myeloid-derived suppressor cells month download article/chapter t-cell response tingmei cheng & rong xiang minigene vaccines similar anti-tumor efficacy tumor cell challenge article cancer immunology immunosuppressive tumor microenvironment full article pdf macrophage activation switching immunotherapy article privacy choices/manage cookies breast cancer vaccine legumain minigene vaccine minigene vaccine proved specific ctl response related subjects legumain kd minigene check access instant access scripps research institute scripps research institute breast tumor model manuscript number 17696-imm inhibit tumor growth inhibits tumor growth dna vaccine huai-dong hu established metastatic disease tumor-microenvironment colon cancer model suppressing tumor angiogenesis tumor protective immunity legumain h-2d murine mhc class article lewēn yunping luo european economic area syngeneic balb/ attenuated salmonella typhimurium control empty vector ifn-γ release findings establish proof adaptive antitumor immunity transgenic mouse model
Schema {🗺️}
WebPage:
mainEntity:
headline:A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
description:Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam
−
, AroA
−
) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
datePublished:2007-09-05T00:00:00Z
dateModified:2007-09-05T00:00:00Z
pageStart:507
pageEnd:515
sameAs:https://doi.org/10.1007/s00262-007-0389-x
keywords:
Legumain
Minigene vaccine
Tumor associated macrophages
Anti-angiogenesis
CTLs
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis
description:Tumor associated macrophages (TAMs) are well known to play a very important role in tumor angiogenesis and metastasis. The suppression of TAMs in the tumor-microenvironment (TME) provides a novel strategy to inhibit tumor growth and dissemination by remodeling the tumor’s stroma. Here, we tested our hypothesis that suppression of TAMs can be achieved in syngeneic BALB/c mice with oral minigene vaccines against murine MHC class I antigen epitopes of Legumain, an asparaginyl endopeptidase and a member of the C13 family of cystine proteases which is overexpressed on TAMs in the tumor stroma. Vaccine vectors were constructed and transformed into attenuated Salmonella typhimurium (Dam
−
, AroA
−
) for oral delivery. Groups of mice received either the expression vectors encoding the Legumain H-2D or 2K epitopes or the control empty vector by gavage. The efficacy of the minigene vaccines was determined by their ability to protect mice from lethal tumor cell challenges, the induction of a specific CTL response as well as IFN-γ release, and inhibition of tumor angiogenesis. We demonstrated that the Legumain minigene vaccine provided effective protection against tumor cell challenge by inducing a specific CD8+ T-cell response against Legumain+ TAMs in our breast tumor model. The protection, induced by this T-cell response, mediated by the Legumain Kd minigene, is also responsible for lysing D2F2 breast carcinoma cells in syngeneic BALB/c mice and for suppressing tumor angiogenesis. Importantly, in a prophylactic setting, the minigene vaccine proved to be of similar anti-tumor efficacy as a vaccine encoding the entire Legumain gene. Together, our findings establish proof of concept that a Legumain minigene vaccine provides a more flexible alternative to the whole gene vaccine, which may facilitate the future design and clinical applications of such a vaccine for cancer prevention.
datePublished:2007-09-05T00:00:00Z
dateModified:2007-09-05T00:00:00Z
pageStart:507
pageEnd:515
sameAs:https://doi.org/10.1007/s00262-007-0389-x
keywords:
Legumain
Minigene vaccine
Tumor associated macrophages
Anti-angiogenesis
CTLs
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-007-0389-x/MediaObjects/262_2007_389_Fig6_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
type:Person
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
type:Person
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:57
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Susanna Lewēn
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:He Zhou
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Huai-dong Hu
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
name:Tingmei Cheng
affiliation:
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
name:Dorothy Markowitz
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Ralph A. Reisfeld
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Rong Xiang
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
name:Chongqing Medical University
address:
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
type:PostalAddress
type:Organization
email:[email protected]
name:Yunping Luo
affiliation:
name:The Scripps Research Institute
address:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
name:Key Laboratory of Molecular Biology for Infectious Disease, Ministry of Education, Institute for Viral Hepatitis, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
name:Department of Immunology, The Scripps Research Institute, La Jolla, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(85)
- How much revenue does https://www.springernature.com/gp/authors produce monthly?
- How much does https://link.springernature.com/home/ rake in every month?
- How much does https://order.springer.com/public/cart net monthly?
- How much profit does https://submission.nature.com/new-submission/262/3 generate?
- Monthly income for https://www.springernature.com/gp/librarians/licensing/agc/journals
- Get to know what's the income of https://doi.org/10.1172%2FJCI27648
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862213 makes per month
- Find out how much http://scholar.google.com/scholar_lookup?&title=Targeting%20tumor-associated%20macrophages%20as%20a%20novel%20strategy%20against%20breast%20cancer&journal=J%20Clin%20Invest&doi=10.1172%2FJCI27648&volume=116&publication_year=2006&author=Luo%2CY&author=Zhou%2CH&author=Krueger%2CJ&author=Kaplan%2CC&author=Lee%2CSH&author=Dolman%2CC&author=Markowitz%2CD&author=Wu%2CW&author=Liu%2CC&author=Reisfeld%2CRA&author=Xiang%2CR earns monthly
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12782603
- How much does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20legumain%20in%20tumors%20is%20significant%20for%20invasion%2Fmetastasis%20and%20a%20candidate%20enzymatic%20target%20for%20prodrug%20therapy&journal=Cancer%20Res&volume=63&publication_year=2003&author=Liu%2CC&author=Sun%2CC&author=Huang%2CH&author=Janda%2CK&author=Edgington%2CT generate monthly?
- How much profit does https://doi.org/10.1158%2F1078-0432.CCR-04-1642 make?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15788679 earning monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Legumain%20expression%20in%20relation%20to%20clinicopathologic%20and%20biological%20variables%20in%20colorectal%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-04-1642&volume=11&publication_year=2005&author=Murthy%2CRV&author=Arbman%2CG&author=Gao%2CJ&author=Roodman%2CGD&author=Sun%2CXF earns monthly
- What are the total earnings of https://doi.org/10.1182%2Fblood-2005-03-0969?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15920006 making per month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=T-cell-mediated%20suppression%20of%20angiogenesis%20results%20in%20tumor%20protective%20immunity&journal=Blood&doi=10.1182%2Fblood-2005-03-0969&volume=106&publication_year=2005&author=Zhou%2CH&author=Luo%2CY&author=Mizutani%2CM&author=Mizutani%2CN&author=Xiang%2CR&author=Reisfeld%2CRA produce monthly?
- How much does https://doi.org/10.1073%2Fpnas.090097697 bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10779556 earn?
- How much money does http://scholar.google.com/scholar_lookup?&title=An%20autologous%20oral%20DNA%20vaccine%20protects%20against%20murine%20melanoma&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.090097697&volume=97&publication_year=2000&author=Xiang%2CR&author=Lode%2CHN&author=Chao%2CTH&author=Ruehlmann%2CJM&author=Dolman%2CCS&author=Rodriguez%2CF&author=Whitton%2CJL&author=Overwijk%2CWW&author=Restifo%2CNP&author=Reisfeld%2CRA make?
- Check the income stats for https://doi.org/10.1073%2Fpnas.1033132100
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12857959?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Transcription%20factor%20Fos-related%20antigen%201%20is%20an%20effective%20target%20for%20a%20breast%20cancer%20vaccine&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1033132100&volume=100&publication_year=2003&author=Luo%2CY&author=Zhou%2CH&author=Mizutani%2CM&author=Mizutani%2CN&author=Reisfeld%2CRA&author=Xiang%2CR have monthly?
- How much does https://doi.org/10.1158%2F0008-5472.CAN-05-1132 generate monthly?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15833877?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20DNA%20vaccine%20targeting%20Fos-related%20antigen%201%20enhanced%20by%20IL-18%20induces%20long-lived%20T-cell%20memory%20against%20tumor%20recurrence&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-1132&volume=65&publication_year=2005&author=Luo%2CY&author=Zhou%2CH&author=Mizutani%2CM&author=Mizutani%2CN&author=Liu%2CC&author=Xiang%2CR&author=Reisfeld%2CRA produce monthly?
- https://doi.org/10.1073%2Fpnas.0502208102's total income per month
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16040807 make?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=DNA-based%20vaccines%20activate%20innate%20and%20adaptive%20antitumor%20immunity%20by%20engaging%20the%20NKG2D%20receptor&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.0502208102&volume=102&publication_year=2005&author=Zhou%2CH&author=Luo%2CY&author=Lo%2CJF&author=Kaplan%2CCD&author=Mizutani%2CM&author=Mizutani%2CN&author=Lee%2CJD&author=Primus%2CFJ&author=Becker%2CJC&author=Xiang%2CR&author=Reisfeld%2CRA?
- https://doi.org/10.1172%2FJCI200421107's financial summary
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15199414
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=A%20novel%20transgenic%20mouse%20model%20for%20immunological%20evaluation%20of%20carcinoembryonic%20antigen-based%20DNA%20minigene%20vaccines&journal=J%20Clin%20Invest&doi=10.1172%2FJCI200421107&volume=113&publication_year=2004&author=Zhou%2CH&author=Luo%2CY&author=Mizutani%2CM&author=Mizutani%2CN&author=Becker%2CJC&author=Primus%2CFJ&author=Xiang%2CR&author=Reisfeld%2CRA?
- Earnings of https://doi.org/10.1038%2Fnm794
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12415261 produce monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=A%20DNA%20vaccine%20against%20VEGF%20receptor%202%20prevents%20effective%20angiogenesis%20and%20inhibits%20tumor%20growth&journal=Nat%20Med&doi=10.1038%2Fnm794&volume=8&publication_year=2002&author=Niethammer%2CAG&author=Xiang%2CR&author=Becker%2CJC&author=Wodrich%2CH&author=Pertl%2CU&author=Karsten%2CG&author=Eliceiri%2CBP&author=Reisfeld%2CRA have?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15634881
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Reduction%20of%20myeloid-derived%20suppressor%20cells%20and%20induction%20of%20M1%20macrophages%20facilitate%20the%20rejection%20of%20established%20metastatic%20disease&journal=J%20Immunol&volume=174&publication_year=2005&author=Sinha%2CP&author=Clements%2CVK&author=Ostrand-Rosenberg%2CS?
- How much profit does https://doi.org/10.1084%2Fjem.176.1.287 generate?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1613462?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Interleukin%204%20potently%20enhances%20murine%20macrophage%20mannose%20receptor%20activity%3A%20a%20marker%20of%20alternative%20immunologic%20macrophage%20activation&journal=J%20Exp%20Med&doi=10.1084%2Fjem.176.1.287&volume=176&publication_year=1992&author=Stein%2CM&author=Keshav%2CS&author=Harris%2CN&author=Gordon%2CS?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16297160 earning monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=Macrophage%20activation%20switching%3A%20an%20asset%20for%20the%20resolution%20of%20inflammation&journal=Clin%20Exp%20Immunol&volume=142&publication_year=2005&author=Porcheray%2CF&author=Viaud%2CS&author=Rimaniol%2CAC&author=Leone%2CC&author=Samah%2CB&author=reuddre-Bosquet%2CN&author=Dormont%2CD&author=Gras%2CG earning monthly?
- What's the financial gain of https://doi.org/10.1016%2FS1357-4310%2899%2901451-3?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10203751
- Earnings of http://scholar.google.com/scholar_lookup?&title=HLA%20class%20I%20antigen%20downregulation%20in%20human%20cancers%3A%20T-cell%20immunotherapy%20revives%20an%20old%20story&journal=Mol%20Med%20Today&doi=10.1016%2FS1357-4310%2899%2901451-3&volume=5&publication_year=1999&author=Hicklin%2CDJ&author=Marincola%2CFM&author=Ferrone%2CS
- Monthly income for https://doi.org/10.1038%2Fsj.onc.1200917
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9050997
- http://scholar.google.com/scholar_lookup?&title=Small%20polydispersed%20circular%20DNA%20%28spcDNA%29%20in%20human%20cells%3A%20association%20with%20genomic%20instability&journal=Oncogene&doi=10.1038%2Fsj.onc.1200917&volume=14&publication_year=1997&author=Cohen%2CS&author=Regev%2CA&author=Lavi%2CS's total income per month
- Discover the revenue of https://doi.org/10.1038%2F37126
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9389480 earn?
- Get to know http://scholar.google.com/scholar_lookup?&title=Antiangiogenic%20therapy%20of%20experimental%20cancer%20does%20not%20induce%20acquired%20drug%20resistance&journal=Nature&doi=10.1038%2F37126&volume=390&publication_year=1997&author=Boehm%2CT&author=Folkman%2CJ&author=Browder%2CT&author=O%E2%80%99Reilly%2CMS's earnings
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0389-x?format=refman&flavour=references rake in every month?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Susanna%20Lew%C4%93n have?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Susanna%20Lew%C4%93n%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=He%20Zhou?
- Profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22He%20Zhou%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Huai-dong%20Hu
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Huai-dong%20Hu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tingmei%20Cheng have?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tingmei%20Cheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Dorothy%20Markowitz makes per month
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Dorothy%20Markowitz%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ralph%20A.%20Reisfeld?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ralph%20A.%20Reisfeld%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rong%20Xiang?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rong%20Xiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yunping%20Luo bring in?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yunping%20Luo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- What's the total monthly financial gain of https://s100.copyright.com/AppDispatchServlet?title=A%20Legumain-based%20minigene%20vaccine%20targets%20the%20tumor%20stroma%20and%20suppresses%20breast%20cancer%20growth%20and%20angiogenesis&author=Susanna%20Lew%C4%93n%20et%20al&contentID=10.1007%2Fs00262-007-0389-x©right=Springer-Verlag&publication=0340-7004&publicationDate=2007-09-05&publisherName=SpringerNature&orderBeanReset=true?
- Check the income stats for https://citation-needed.springer.com/v2/references/10.1007/s00262-007-0389-x?format=refman&flavour=citation
- What's the revenue for https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- What's https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's gross income?
- Learn about the earnings of https://www.springernature.com/gp/products
- How much does https://www.springernature.com/gp/librarians earn?
- How much money does https://www.springernature.com/gp/societies make?
- What are the earnings of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ net monthly?
- How much does https://www.nature.com/ pull in monthly?
- What's the monthly money flow for https://www.biomedcentral.com/?
- Get to know what's the income of https://www.palgrave.com/
- How much does https://www.apress.com/ rake in every month?
- Learn about the earnings of https://www.springernature.com/gp/legal/ccpa
- Get to know https://www.springernature.com/gp/info/accessibility's earnings
- What's the total monthly financial gain of https://support.springernature.com/en/support/home?
- What's the financial gain of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Discover the revenue of https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref